Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastasis From Malignant Tumor of Prostate”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Active Not RecruitingNCT07174063
What this trial is testing

A Phase I Study of JSB462 (Luxdegalutamide) in Japanese Patients With Metastatic Prostate Cancer

Who this might be right for
Metastatic Prostate Cancer (mCRPC)
Novartis Pharmaceuticals 6
Not applicableStudy completedNCT04048252
What this trial is testing

Development of a Therapeutic Education Program for Patients With Metastatic Prostate Cancer Treated With New Generation Hormone Therapy

Who this might be right for
Prostate Cancer
Centre Hospitalier Universitaire de Nīmes 18
Testing effectiveness (Phase 2)UnknownNCT05212857
What this trial is testing

Enhanced Systemic Combined With Local Treatment for Primary and Metastatic Lesions in Oligo-metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
Fudan University 160
Large-scale testing (Phase 3)Active Not RecruitingNCT03748641
What this trial is testing

Niraparib in Combination With Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone for Treatment of Participants With Metastatic Prostate Cancer

Who this might be right for
Castration-Resistant Prostatic Cancer
Janssen Research & Development, LLC 765
Testing effectiveness (Phase 2)Study completedNCT00239291
What this trial is testing

Safety Study to Explore Combination of Gefitinib (ZD1839, Iressa) and Radiotherapy in Non-Metastatic Prostate Cancer

Who this might be right for
Non-Metastatic Prostate Cancer
AstraZeneca 42
Not applicableStudy completedNCT02066961
What this trial is testing

Describe Patterns of Care and Outcomes of Men Who Are at High Risk After Experiencing Biochemical Failure Following Definitive Prostate Cancer Therapy, Men With Castration-resistant Prostate Cancer and Men With Metastatic Prostate Cancer

Who this might be right for
Prostate CancerCastration-resistant Prostate CancerMetastatic Prostate Cancer
Astellas Pharma Global Development, Inc. 1,533
Testing effectiveness (Phase 2)Study completedNCT01677897
What this trial is testing

Impact of the Addition of Metformin to Abiraterone in Metastatic Prostate Cancer Patients

Who this might be right for
Metastatic Prostate Cancer
Kantonsspital Graubünden 25
Testing effectiveness (Phase 2)Active Not RecruitingNCT04663997
What this trial is testing

177 LuPSMA-617 vs Docetaxel in Metastatic Castration Resistant and PSMA-Positive Prostate Cancer

Who this might be right for
Prostate Cancer
Canadian Cancer Trials Group 200
Testing effectiveness (Phase 2)Active Not RecruitingNCT05751941
What this trial is testing

Study of Sipuleucel-T With or Without Continuing New Hormonal Agents in Metastatic Prostate Cancer

Who this might be right for
Prostate CancerMetastatic Prostate Cancer
H. Lee Moffitt Cancer Center and Research Institute 26
Early research (Phase 1)Ended earlyNCT03619655
What this trial is testing

Assessment of Multi-Modality Quantitative Imaging for Evaluation of Response of Metastatic Prostate Cancer to Therapy

Who this might be right for
Prostate Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 3
Not applicableLooking for participantsNCT07209176
What this trial is testing

Physician- and Patient-based Barriers to NGS Testing

Who this might be right for
Metastatic Prostate Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 256
Testing effectiveness (Phase 2)Study completedNCT01075308
What this trial is testing

SB939 in Treating Patients With Recurrent or Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
NCIC Clinical Trials Group 32
Testing effectiveness (Phase 2)Looking for participantsNCT07038304
What this trial is testing

The Impact of Metastatic Directed Radiotherapy (MDRT) on Oligoprogressive Castration Resistant Prostate Cancer (CRPC)

Who this might be right for
Prostate Cancer (Adenocarcinoma)OligoProgressive Metastatic DiseaseCastration Resistant Metastatic Prostate Cancer+1 more
University Medical Center Groningen 35
Not applicableLooking for participantsNCT06600802
What this trial is testing

Intrinsic Validity of Molecular Marker(s) Detection on Tissular Tumoral DNA to Predict the Efficacy of 177Lutetium-PSMA-617 (Lu-PSMA) Treatment for Castration-resistant Metastatic Prostate Cancer

Who this might be right for
Castration-resistant Metastatic Prostate CancerTreated by 177Lutetium-PSMA-617 (Lu-PSMA)
Centre Jean Perrin 120
Not applicableLooking for participantsNCT05242744
What this trial is testing

FTT PET/CT in Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer Metastatic
Abramson Cancer Center at Penn Medicine 30
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07310433
What this trial is testing

Dapagliflozin Combined With Next-generation Hormonal Agent (NHA) Versus Single NHA in Participants With Metastatic Castrate-resistant Prostate Cancer

Who this might be right for
Prostate CancerMetastatic Prostate Cancer
Yung NA 60
Very early researchLooking for participantsNCT07608848
What this trial is testing

First-in-human Diagnostic Imaging Profile of the Theranostic Pair [68Ga]Ga-DOTA-STR-17126 and Low Dose [177Lu] Lu-DOTA-STR-17126 in Patients With Advanced or Metastatic Cancer

Who this might be right for
Metastatic Breast CancerMetastatic Prostate CancerGRPR-Targeted Molecular Imaging+5 more
Integrated Haematology and Oncology Network 20
Early research (Phase 1)Looking for participantsNCT06343038
What this trial is testing

Targeted Radionuclide Therapy in Metastatic Prostate Cancer Using a New PSMA Ligand Radiolabelled With Terbium-161 (161Tb-SibuDAB) - Dose Identification/Escalation Phase Ia/b Study

Who this might be right for
Castration-resistant Prostate Cancer
University Hospital, Basel, Switzerland 25
Not applicableLooking for participantsNCT07538843
What this trial is testing

An Observational Study Conducted in China to Evaluate the Efficacy and Safety of Darolutamide in Combination With Androgen Deprivation Therapy (ADT) for Men With Non-metastatic Prostate Cancer That Progressed Following Prior Bicalutamide + ADT Treatment

Who this might be right for
Non-metastatic Castration-resistant Prostate Cancer
Bayer 800
Early research (Phase 1)Looking for participantsNCT07581184
What this trial is testing

[225Ac]Ac-AKY-2519 in Patients With Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Castration Resistant Metastatic Prostate CancerProstate CancermCRPC (Metastatic Castration-resistant Prostate Cancer)+2 more
Aktis Oncology, Inc. 138
Next Page